ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,872Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 113

$596K Total Retail Price of All Prescriptions

Rank: 15 out of 113

559 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 13,212 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 734 679 1 2
LEVOTHYROXINE SODIUM 682 654 2 1
FUROSEMIDE 516 493 3 6
AMLODIPINE BESYLATE 451 425 4 4
OMEPRAZOLE 407 397 5 5
WARFARIN SODIUM 395 383 6 8
LISINOPRIL 393 376 7 3
LOSARTAN POTASSIUM 356 356 8 13
POTASSIUM CHLORIDE 336 323 9 12
METOPROLOL SUCCINATE 327 317 10 10
HYDROCODONE-ACETAMINOPHEN 286 284 S3 11 7
SERTRALINE HCL 237 224 12 21
FENTANYL 225 225 S2 13 43
HYDROCHLOROTHIAZIDE 219 208 14 9
METOPROLOL TARTRATE 205 193 15 14
GABAPENTIN 192 192 16 18
SPIRONOLACTONE-HCTZ 177 163 17 107
ATORVASTATIN CALCIUM 176 172 18 15
METFORMIN HCL 169 162 19 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 158 20 34
ALENDRONATE SODIUM 160 159 21 22
TRAMADOL HCL 157 156 22 29
SPIRONOLACTONE 149 137 23 32
GLIMEPIRIDE 136 132 24 36
CITALOPRAM HBR 130 117 25 17
ATENOLOL 123 117 26 16
MIRTAZAPINE 119 117 27 71
POLYETHYLENE GLYCOL 3350 117 116 28 77
MELOXICAM 113 109 29 44
CARBIDOPA-LEVODOPA 101 101 30 73
SYNTHROID 98 98 31 57
ZOLPIDEM TARTRATE 97 93 32 19
FLUOXETINE HCL 96 96 33 31
ALLOPURINOL 96 73 33 20
FELODIPINE ER 95 95 35 95
NAMENDA 95 95 35 48
FAMOTIDINE 90 85 37 71
PAROXETINE HCL 89 72 38 45
LOSARTAN-HYDROCHLOROTHIAZIDE 84 81 39 40
CARVEDILOL 83 83 40 25
TRIAMTERENE-HCTZ 81 75 41 26
PRAVASTATIN SODIUM 81 81 41 23
OXYBUTYNIN CHLORIDE 73 60 43 89
LOVASTATIN 71 70 44 53
OLANZAPINE 69 59 45 88
NEXIUM 69 49 45 47
CRESTOR 69 65 45 30
ATENOLOL-CHLORTHALIDONE 67 67 48 176
TRAZODONE HCL 66 65 49 41
DIGOXIN 64 64 50 27
COMBIVENT 63 63 51 99
IRBESARTAN 62 58 52 99
PREMARIN 60 60 R 53 69
OXYBUTYNIN CHLORIDE ER 60 60 53 112
DIOVAN 59 51 55 42
ADVAIR DISKUS 59 57 55 35
PANTOPRAZOLE SODIUM 59 57 55 52
CYMBALTA 57 51 58 37
GEMFIBROZIL 57 53 58 61
FLUTICASONE PROPIONATE 56 56 60 39
PROAIR HFA 55 55 61 64
AMITRIPTYLINE HCL 53 40 R 62 58
LANTUS 51 51 63 38
BUPROPION HCL SR 51 51 63 153
TRIAMCINOLONE ACETONIDE 50 50 65 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.